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Abstract. 
 
Although growth factor receptors are gener-
ally thought to carry out their role in signal transduc-
tion at the cell surface, many of these transmembrane
proteins translocate to the nucleus after ligand stimu-
lation. Here, we show that the nuclear translocation of
 
ﬁbroblast growth factor receptor (FGFR)1 occurs via a
mechanism distinct from classical nuclear import but de-
 
pendent on importin 
 
b
 
, a component of multiple nuclear
import pathways. Furthermore, we show that nuclear
FGFR1 induces c-Jun and is involved in the regulation of
cell proliferation. These data are the ﬁrst description of a
nuclear import pathway for transmembrane growth fac-
tor receptors and elucidate a novel signal transduction
pathway from the cell surface to the nucleus.
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Introduction
 
Growth factors regulate a diverse array of cellular func-
tions, ranging from proliferation and apoptosis to migra-
tion and differentiation. Mutations in growth factor signal-
ing pathways are the cause of many cancers. The vast
majority of growth factors act on cells by binding to spe-
cific transmembrane receptors at the cell surface, which
activate ligand-dependent intracellular signaling networks,
typically via the interaction of effector proteins with the
activated receptor. Ultimately, these pathways exert their
effects on cells by regulating gene expression, often via the
nuclear translocation of a downstream kinase and the sub-
sequent phosphorylation of nuclear substrates.
 
In addition to events occurring at the plasma membrane,
evidence is accumulating for growth factor receptor func-
tion after internalization. For example, internalized EGF
receptor has been reported to activate both phospholipase
 
C
 
g
 
 and Ras (Haugh et al., 1999a,b), and internalized TrkA
regulates nerve growth factor–induced neuronal differentia-
tion (Zhang et al., 2000). After internalization, many trans-
membrane receptors are translocated to the nucleus, includ-
 
ing FGF receptor (FGFR)
 
1
 
 1, TrkA, insulin receptor,
growth hormone receptor, receptors for interferons and in-
terleukins, angiotensin type 1 receptor, and TGF-
 
b
 
 type I
receptor (Jans and Hassan, 1998; Lu et al., 1998; Zwaagstra
et al., 2000). In many cases, including FGFR1, neither the
ligand nor the receptor harbors a nuclear localization signal
(NLS), and little is known about the mechanism of nuclear
import of the receptor. Furthermore, no definitive function
for nuclear growth factor receptors has yet been elucidated.
FGFR1 is activated by members of the FGF family, in-
cluding basic FGF (FGF-2) (Bikfalvi et al., 1997). Multiple
FGF-2 isoforms result from alternative translational initia-
tion, giving rise to 21–24-kD forms with limited tissue distri-
bution and a ubiquitously expressed 18-kD form (Vagner et
al., 1996). The higher molecular weight isoforms contain
functional NLSs, whereas the 18-kD isoform does not (Flor-
kiewicz et al., 1991). However, treatment of cells with 18 kD
FGF-2 results in the nuclear translocation of FGFR1 (Ma-
her, 1996b) despite the lack of an NLS in either the ligand
or the receptor. We undertook the present study to define
the functional roles of nuclear FGFR1 and determine the
mechanism of its transport into the nucleus. We show that
nuclear translocation of FGFR1 is mediated by importin 
 
b
 
and that FGFR1 in the nucleus plays a role in the regulation
of the cell cycle.
 
Materials and Methods
 
Cell Fractionation and Immunoblotting
 
Swiss 3T3 cells were grown as described previously (Maher, 1996b) and
treated with recombinant human FGF-2 (25 ng/ml). Cellular stores of
 
ATP were depleted with oligomycin B (50 
 
m
 
M) and 2-deoxyglucose (6
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mM) in glucose-free DME containing 0.5% dialyzed serum for the indi-
cated times. Cytosolic and nuclear fractions were prepared as described
previously (Schreiber et al., 1989; Maher, 1996b). Western blotting and
immunoprecipitation were as described previously (Reilly et al., 2000), us-
ing antibodies against the Xpress epitope tag, EGFR, c-Jun, c-Fos, c-Myc,
cyclin E, and importin 
 
b
 
 (Santa Cruz Biotechnology, Inc.), phospho-c-Jun
(New England Biolabs, Inc.), cyclin D1 and p27
 
Kip1
 
 (NeoMarkers),
PDGFR (Upstate Biotechnology), and FGFR (mAb6) (Maher, 1996b).
Protein concentrations were determined using the bicinchoninic acid pro-
tein assay (Pierce Chemical Co.), and equal loading was verified by stain-
ing blots with Ponceau 
 
S
 
 and quantifying the eluted dye by spectropho-
tometry. ATP concentrations of cytosolic fractions were determined using
a commercial assay kit (Sigma-Aldrich). Densitometry of blots was per-
formed using NIH Image v1.62, and statistical comparisons were per-
formed using Student’s 
 
t
 
 test.
 
Confocal Microscopy
 
Swiss 3T3 cells were plated at low density on glass coverslips in DME con-
taining 0.5% serum and treated with FGF-2 (25 ng/ml). Cellular stores of
ATP were depleted as above. After treatment, cells were immunostained
for FGFR1 as described previously (Maher, 1996b), and nuclei were coun-
terstained with TO-PRO-3 or SYTOX Green (Molecular Probes). Optical
sections were collected using a Bio-Rad MRC1024 laser scanning confocal
microscope attached to a ZEISS Axiovert 100TV. In all cases, optical sec-
tions were through the median plane of the nucleus, as determined by nu-
clear counterstaining.
 
Nuclear Import Assay
 
Assays were carried out using Swiss 3T3 cells essentially as described
(Adam et al., 1990). Cells grown on coverslips were washed in transport
buffer (20 mM Hepes, pH 7.3, 110 mM KOAc, 5 mM NaOAc, 2 mM
Mg[OAc]
 
2
 
, 1 mM EGTA, 2 mM DTT, and 1 
 
m
 
g/ml each aprotinin, leupep-
tin, and pepstatin) and permeabilized with 75 
 
m
 
M digitonin (Calbiochem).
Nuclear import assays were carried out at 30
 
8
 
C in transport buffer with an
ATP regenerating system (1 mM ATP, 5 mM creatine phosphate, 20 U/ml
creatine phosphokinase) (Calbiochem) and 50% rabbit reticulocyte lysate
(Promega). FGF-2 was added at 50 ng/ml. Importin 
 
b
 
 was depleted from
the rabbit reticulocyte lysate with mAb3E9 (Affinity Bioreagents, Inc.)
and anti–mouse agarose (Sigma-Aldrich). Mock immunodepletion was
performed with purified mouse IgG. For antibody inhibition of importin
 
b
 
, mAb3E9 ascites fluid was diluted 1:4 with transport buffer containing 5
mg/ml BSA and dialyzed against transport buffer. A fluorescent transport
substrate (Cy5-NLS-BSA) was used to verify the effects of treatments on
classical NLS-mediated nuclear import. Immunostaining for FGFR1 and
confocal microscopy were as described above.
 
Plasmid Construction and Transfection
 
An expression vector encoding a COOH-terminal epitope tag was con-
structed from pcDNA3.1/HisA as follows: the vector was digested with
HindIII and KpnI to excise the epitope tag and the ends were blunted
then ligated. Bases 926–1013 of the original vector were amplified by PCR
with an XbaI site appended to the 5
 
9
 
 end and a stop codon followed by an
ApaI site appended to the 3
 
9
 
 end. After digestion, this fragment was li-
gated into the XbaI/ApaI-digested vector lacking the epitope tag.
Full-length wild-type FGFR1, NLS-R1, and 
 
D
 
SP-R1 were generated by
PCR with the following forward primers: FGFR1, 5
 
9
 
-GCGG-
ATCCATGTGGAGCTGGAAGTGCCTCCTC-3
 
9
 
; NLS-R1, 5
 
9
 
-GCGG-
ATCCATGGACCCAAAAAAGAAGAGAAAGGTAAGGCCGTCC-
CCGACCTTG-3
 
9
 
; 
 
D
 
SP-R1, 5
 
9
 
-CCGGATCCATATGAGGCCGTCC-
CCGACCTTG-3
 
9
 
; and the reverse primer, 5
 
9
 
-CGCTCGAGGCG-
GCGTTTGAGTCCCCGATTGGC-3
 
9
 
. All three were subcloned into
pcDNA3.1/HisA/C-term. The NLS-R1 construct encodes a methionine
followed by the SV-40 large T antigen NLS (DPKKKRKV) appended to
the NH
 
2 
 
terminus of the mature FGFR1 protein (amino acids 22–822).
The 
 
D
 
SP-R1 construct encodes the mature FGFR1 protein (amino acids
22–822) with a methionine appended to the NH
 
2 
 
terminus. The NLS-
R1kd construct was generated by subcloning the KpnI-Bsu36I fragment
of CD-R1 K514M (Reilly et al., 2000) into the corresponding region of
the NLS-R1 plasmid. The vector and constructs were verified by DNA
sequencing.
For transient transfections, NIH 3T3 cells were seeded at 4 
 
3
 
 10
 
5
 
 cells/
cm
 
2
 
, grown for 18 h in DME supplemented with 10% calf serum, and then
transfected using Lipofectamine 2000 (GIBCO BRL) according to the
manufacturer’s protocol. Cells were maintained in DME supplemented
with 10% calf serum for 24 h, starved for 24 h, and then treated with re-
combinant human FGF-2.
 
Results and Discussion
 
Nuclear Import of FGFR1
 
Participation of nuclear FGFR1 in FGF-induced signal
transduction events requires regulated transport of the re-
ceptor into the nucleus. In examining the energy depen-
dence of FGF-2–induced nuclear accumulation of FGFR1,
we observed that ligand-induced nuclear translocation oc-
curred in fibroblasts depleted of ATP using a combination
of oligomycin B and 2
 
9
 
-deoxyglucose (Fig. 1). Interest-
ingly, ATP depletion also induced the nuclear transloca-
Figure 1. FGF and depletion
of ATP induce the nuclear
translocation of FGFR1. (a)
Swiss 3T3 fibroblasts were
untreated or subjected to
ATP depletion by treatment
with oligomycin B and 2-deoxy-
glucose for 4 h and analyzed
by FGFR1 immunostaining
and confocal microscopy. The
onset of ATP depletion and
FGF-2 treatment was simulta-
neous. Nuclear localization
was confirmed by fluorescent
nuclear counterstaining (data
not shown). (b) Cells treated
as in “a” were separated into
cytosolic (C) and nuclear (N)
fractions, and equal amounts
of protein were immunoblot-
ted for FGFR1. FGFR1 is
detected as bands migrating at 145 and 120 kD, representing alternative splice variants (Johnson and Williams, 1993). (c) Cellular ATP
concentration and percent of FGFR1 in the nuclear fraction during ATP depletion. Cells were pretreated with FGF-2 for 1 h before the
onset of ATP depletion. Nuclear FGFR1 was determined by densitometry of FGFR1 immunoblots, and values represent the mean 6
SEM of triplicate experiments. Bar, 30 mm. 
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tion of FGFR1 in the absence of FGF-2. Confocal mi-
croscopy
 
 
 
demonstrated the localization of FGFR1 in
untreated cells to the plasma membrane and in vesicle-like
structures within the cytoplasm (Fig. 1 a; see Fig. 4 b for
higher magnification). The low level of plasma membrane
staining is a result of the technique used to permeabilize
the cells (Maher, 1996b), and cytoplasmic localization of
FGFR1 has been described previously (Maher, 1996a). In
FGF-2–treated cells, FGFR1 was located within the nu-
cleus and not associated with the nuclear envelope (Fig. 1
a). ATP depletion caused morphological changes in the
cells, including shrinkage of the cell body and nucleus. Lo-
calization of FGFR1 in the nucleus of ATP-depleted cells
was confirmed by differential interference contrast mi-
croscopy, and FGFR1 immunoreactivity was coincident
with a fluorescent nuclear counterstain (data not shown).
These data were confirmed by biochemical isolation of
membrane-depleted nuclei (Fig. 1 b). As ATP concentra-
tions within cells decreased, a progressive increase in the
nuclear accumulation of FGFR1 was observed, and this ef-
fect was potentiated at all time points by pretreatment
with FGF-2 (Fig. 1 c).
To rule out the possibility that the effects of ATP deple-
tion on the nuclear localization of FGFR1 represent a
nonspecific translocation of cell surface receptors, we ex-
amined the localization of PDGF receptor and EGF re-
ceptor in ATP-depleted cells (Fig. 2 a). Depletion of ATP
did not induce the nuclear accumulation of either recep-
tor, indicating that the observed effects are specific for
FGFR1. Additionally, ATP depletion did not result in the
nuclear accumulation of ERK1 and 2, proteins which nor-
mally translocate to the nucleus after growth factor stimu-
lation of cells (data not shown). To rule out the possibility
that the effects of ATP depletion on the nuclear localiza-
tion of FGFR1 were due to a generalized response to cel-
lular stress, we subjected cells to osmotic shock, which did
not result in nuclear accumulation of FGFR1 (Fig. 2 b).
 
Importin 
 
b 
 
Mediates FGFR1 Nuclear Import
 
Importin 
 
b
 
 is a critical component of multiple nuclear im-
port pathways (Nakielny and Dreyfuss, 1999). Recently, it
was reported that microinjected importin 
 
b
 
 accumulates in
the nucleus of ATP-depleted cells, whereas export of im-
portin 
 
b
 
 from the nucleus is energy-dependent (Kose et
al., 1999), characteristics similar to those of FGFR1. To
 
determine if importin 
 
b
 
 is involved in the nuclear import
of FGFR1, we first examined the localization of endoge-
nous importin 
 
b
 
 in ATP-depleted cells. In untreated cells
and cells treated with FGF-2, importin 
 
b
 
 was localized al-
most exclusively in the cytosol. Depletion of ATP resulted
in a progressive nuclear accumulation of importin 
 
b
 
, and
this effect was potentiated by FGF-2 (Fig. 3). These data
are consistent with a model in which energy is required to
export importin 
 
b
 
 from the nucleus. In the ATP-depleted
state, importin 
 
b
 
 that enters the nucleus during endoge-
nously occurring transport fails to be exported. The poten-
tiation of importin 
 
b
 
 nuclear accumulation by FGF-2 sug-
gests that importin 
 
b
 
 plays a role in the nuclear import of
FGFR1. Alternatively, since activation of FGF-induced
signaling pathways results in the nuclear translocation of
transcription factors such as NF-
 
k
 
B (Byrd et al., 1999), im-
portin 
 
b
 
 may accumulate in the nucleus of ATP-depleted,
FGF-2–treated cells after import of NLS-bearing cargoes.
To establish a direct role for importin 
 
b
 
 in the nuclear im-
port of FGFR1, we initially demonstrated the presence of a
complex containing FGFR1 and importin 
 
b
 
 in the nucleus
of ATP-depleted cells by coimmunoprecipitation of impor-
tin 
 
b
 
 with FGFR1 (Fig. 4 a). For treatment times up to 4 h,
the amount of importin 
 
b
 
 which coprecipitates with FGFR1
is proportional to the amount of importin 
 
b
 
 detected in the
nuclear fractions (data not shown). In cells treated with
FGF-2 but not depleted of ATP, the complex most likely
dissociates, followed by reexport of the importin 
 
b
 
 from
the nucleus. Precipitation of importin 
 
b
 
 was not observed
in control experiments using preimmune IgG (data not
shown). The physical association of importin 
 
b
 
 with FGFR1
supports the hypothesis of a functional role in import. This
role was confirmed using the well-characterized in vitro nu-
clear import assay in digitonin-permeabilized cells (Adam
et al., 1990). In nonpermeabilized cells, treatment with
FGF-2 resulted in the nuclear accumulation of FGFR1 (Fig.
4 b). Permeabilization of cells with digitonin has been
shown to release 
 
z
 
20% of the total cellular protein and to
extract the soluble factors necessary for nuclear import
(Adam et al., 1990), including 
 
$
 
80% of the importin 
 
b
 
 (Chi
et al., 1995). FGF-2–induced nuclear import of FGFR1 was
inhibited in digitonin permeabilized fibroblasts and recon-
stituted by the addition of exogenous cytosol (Fig. 4 c), indi-
cating that soluble factors are necessary for the nuclear im-
port of FGFR1. Immunodepletion of importin 
 
b
 
 from the
exogenous cytosol (Chi et al., 1995) blocked the import of a
fluorescently labeled transport substrate (Cy5-NLS-BSA)
(data not shown). This treatment also inhibited FGF-
2–induced nuclear import of FGFR1 (Fig. 4 d), whereas
mock-depletion of the exogenous cytosol with preimmune
mouse IgG had no effect. In an alternate approach, addition
of a monoclonal antibody against importin 
 
b
 
 to exogenous
cytosol also blocked FGF-2–induced nuclear import of
Figure 2. The effects of ATP
depletion are specific for
FGFR1. (a) Cells were un-
treated or subjected to ATP
depletion by treatment with
oligomycin B and 2-deoxy-
glucose  for 2 h, separated into
cytosolic (C) and nuclear (N)
fractions, and equal amounts
of protein were immunoblot-
ted for PDGF receptor
(PDGFR) or EGF receptor
(EGFR). Molecular weights
are indicated in kD. (b) Cells
were untreated or subjected
to osmotic shock (300 mM sorbitol, 1 h), separated into cytosolic
(C) and nuclear (N) fractions, and equal amounts of protein were
immunoblotted for FGFR1.
Figure 3. ATP depletion in-
duces the nuclear translocation
of importin b. Cells were un-
treated or subjected to ATP
depletion by treatment with
oligomycin B and 2-deoxyglu-
cose for the indicated times, in
the absence or presence of FGF-2. Cells were separated into cytoso-
lic (C) and nuclear (N) fractions, and equal amounts of protein were
immunoblotted for importin b. 
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FGFR1 (Fig. 4 e). These data demonstrate that importin 
 
b
 
mediates the nuclear import of FGFR1.
Our findings provide the first description of a mecha-
nism for the nuclear import of a transmembrane receptor
tyrosine kinase. The phenomenon of nuclear translocation
of receptors is well established for steroid hormone recep-
tors and orphan nuclear receptors but has met with some
controversy concerning transmembrane growth factor re-
ceptors. Nuclear localization has been demonstrated by
biochemical and microscopic means for many transmem-
brane receptors (Jans and Hassan, 1998), including a seven
transmembrane domain receptor (Lu et al., 1998). Argu-
ments that nuclear localization is an artifact have been
made based in part on the lack of a defined mechanism for
nuclear import, since most transmembrane receptors lack
NLSs. By providing direct evidence of importin 
 
b
 
–medi-
ated nuclear import of FGFR1, which does not contain an
NLS, our data resolve this issue.
 
Role of Nuclear FGFR1 in Cell Proliferation
 
To examine the functional role of nuclear FGFR1, we
transfected mouse fibroblasts with a construct encoding
full-length FGFR1 with the signal peptide replaced by the
SV-40 large T antigen NLS. This protein (NLS-R1) was
constitutively localized to the nucleus (Fig. 5 a), as deter-
mined by biochemical fractionation of the cells. Cells ex-
pressing NLS-R1 showed elevated expression of c-Jun
compared with cells transfected with wild-type FGFR1
(Fig. 5 b) or with a construct encoding FGFR1 lacking the
signal peptide (
 
D
 
SP-R1) or with vector alone (data not
 
shown). A construct encoding NLS-R1 with a point muta-
tion that inactivates the tyrosine kinase (NLS-R1kd) failed
to stimulate c-Jun expression, demonstrating that the ob-
served responses depend on receptor kinase activity. The
basal levels of two other immediate early gene products,
c-Fos and c-Myc, were unaffected by NLS-R1 when com-
pared with the expression in cells transfected with wild-
type FGFR1 (Fig. 5 b). Treatment with FGF-2 induced the
expression of c-Jun, c-Fos, and c-Myc in FGFR1 and NLS-
R1–transfected cells, and FGF-2–induced c-Jun expression
was potentiated in NLS-R1–transfected cells compared
with cells transfected with wild-type FGFR1 (Fig. 5 b). The
level of c-Jun expression in unstimulated FGFR1–trans-
fected cells was similar to that in vector-transfected con-
trols and most likely represents incomplete quiescence due
to the transfection procedure or the duration of the serum
deprivation. This increased baseline expression may be
masking part of the stimulatory effects of NLS-R1. In addi-
tion to immediate early gene expression, several other
FGF-induced signal transduction events were examined in
cells transfected with vector, FGFR1, 
 
D
 
SP-R1, or NLS-R1.
No significant differences were observed in basal or FGF-
stimulated phosphorylation of ERK1/2, p38 MAPK,
CREB, ATF-2, Akt/PKB, or p70
 
S6K
 
 (data not shown). This
is consistent with the activation of these kinase modules
and their downstream effectors by cell surface FGFR1 and
indicates that the induction of c-Jun by NLS-R1 is a spe-
cific result of the nuclear localization of the receptor.
c-Jun and c-Fos are components of the heterodimeric
transcription factor AP-1, and both are required for cell
Figure 4. Nuclear import of
FGFR1 is mediated by impor-
tin b. (a) Coimmunoprecipita-
tion of importin b with
FGFR1. Cells were untreated
or subjected to ATP depletion
by treatment with oligomycin
B and 2-deoxyglucose for 2 h,
in the absence or presence of
FGF-2,  and separated into
cytosolic (C) and nuclear (N)
fractions. FGFR1 was immu-
noprecipitated from equal
amounts of protein, and com-
plexes were separated by
SDS-PAGE and immuno-
blotted for importin b. The
whole cell lysate is shown for
comparison, the immuno-
globulin heavy chain (IgG) is
indicated, and molecular
weights are indicated in kD.
(b–e) Nuclear translocation
of FGFR1 in Swiss 3T3 fibro-
blasts was examined using an
in vitro nuclear import assay
(Adam et al., 1990), and cells
were analyzed by FGFR1 im-
munostaining  and confocal
microscopy. Unpermeabi-
lized cells (b) were untreated or incubated for 30 min with FGF-2. Digitonin-permeabilized cells (c–e) were incubated for 30 min with
FGF-2 in the absence or presence of exogenous cytosol (c), with mock- or importin b–depleted exogenous cytosol (d) or with exoge-
nous cytosol plus mouse IgG or a neutralizing antibody against importin b (e). Depletion of importin b from exogenous cytosol was
confirmed by immunoblotting (d). Bar, 10 mm. 
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proliferation (Kovary and Bravo, 1991). c-Jun is also ac-
tive as a homodimer, and its role in cell proliferation is me-
diated at least in part by direct activation of the cyclin D1
promoter (Bakiri et al., 2000). Cyclins and their cyclin-
dependent kinase partners control cell cycle progression
(Johnson and Walker, 1999). Cyclin D1 is the principal G
 
1
 
-
phase cyclin and is induced by multiple growth factors
including FGF-2. In NLS-R1–transfected cells, FGF-
induced cyclin D1 expression was potentiated compared
with cells transfected with FGFR1 (Fig. 5 c), demonstrat-
ing a role for nuclear FGFR1 in the regulation of cell pro-
liferation. However, despite the increase in basal c-Jun ex-
pression, no increase in the basal expression of cyclin D1
was observed in NLS-R1–transfected cells. c-Jun activity is
regulated by both expression level and NH
 
2
 
-terminal
phosphorylation, and phosphorylation is required for the
full activity of c-Jun, induction of cyclin D1 expression,
and cell proliferation (Behrens et al., 1999; Bakiri et al.,
2000). Treatment of cells with FGF results in the activa-
tion of c-Jun NH
 
2
 
-terminal kinase (data not shown). How-
ever, the c-Jun expressed in untreated NLS-R1–trans-
fected cells is not strongly phosphorylated, as determined
by immunoblotting with a phosphospecific antibody,
whereas the NLS-R1–potentiated increase in c-Jun ex-
pression in FGF-treated cells is accompanied by an in-
crease in c-Jun phosphorylation (data not shown). Our
data suggest that c-Jun activity represents a convergence
point for FGFR1 signaling, with nuclear localization of
the receptor inducing c-Jun expression and cell surface
FGFR1-mediated c-Jun NH
 
2
 
-terminal kinase activation
resulting in c-Jun phosphorylation.
Induction of cyclin D1 is only one of the required events
in G
 
1
 
-phase progression and is accompanied by degrada-
tion of the cyclin-dependent kinase inhibitor p27
 
Kip1
 
 and
 
the induction of cyclin E (Johnson and Walker, 1999).
FGF-induced degradation of p27
 
Kip1
 
 was not affected by
nuclear FGFR1 (Fig. 5 c), nor was induction of cyclin E
(data not shown). Consistent with these observations, no
potentiation of basal or FGF-induced DNA synthesis was
seen in NLS-R1–transfected cells (data not shown). These
data support a model in which activation of FGFR1 at the
cell surface initiates a set of signals required for prolifera-
tion, and these events are followed by translocation of
FGFR1 to the nucleus and initiation of a subsequent set of
events, including c-Jun induction and increased expression
of cyclin D1, that are also required for proliferation.
Our data define a specific role for importin 
 
b
 
–mediated
nuclear translocation of FGFR1 in immediate early gene
induction and cell proliferation, providing direct evidence
for a nuclear function of a cell surface growth factor recep-
tor. These studies suggest that regulated nuclear import of
transmembrane receptors represents an additional mode
of signal transduction, complementing the well character-
ized pathways of cytoplasmic kinase cascades.
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